ArticleNeuro-oncology2020

Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.

C Mircea S Tesileanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.